baber/WOPTO huggingface dataset:
Patent PT-1707077-E (PT)
Title: Storage tray for storing and watering plants, and watering device
Inventor: KORTE HERMANN
IPC: A47B43/00
Filed: 2005-12-09
Abstract: The tray (101) to hold plants, for storage and transport and watering, has a rectangular shape with a base (103) and side walls (105). Two holders (130) are at each of the parallel narrow sides (106a) for suspension at the struts of a wheeled frame. Each holder lies along the narrow sides, with a free end section towards the longitudinal sides (106b,106c) for suspension. Two of the holders are at the corners (120) of the tray. Two openings (107) carry out any water overflow.
Patent PT-1725536-E (PT)
Title: Imidazoline derivatives having cb1-antagonistic activity
Inventor: KRUSE CORNELIS G
IPC: C07D233/28
Filed: 2005-02-16
Abstract: The present invention relates to 1,2,4-tri-substituted imidazoline derivatives, to methods for the preparation of these compounds, to novel intermediates useful for the synthesis of said imidazoline derivatives, to methods for the preparation of these intermediates, to pharmaceutical compositions containing one or more of these imidazoline derivatives as active ingredient, as well as to the use of these pharmaceutical compositions for the treatment of psychiatric and neurological disorders. The compounds have the general formula (I) wherein the symbols have the meanings given in the specification.
Patent PT-1833907-E (PT)
Title: Polyethylene composition for artificial turf
Inventor: LAMBERT YVES-JULIEN
IPC: D01F1/04
Filed: 2005-12-09
Abstract: Pigmented tape, fibre or filament comprising 75-99.5 wt % of an unpigmented polyethylene having a density of 928-940 kg/m<SUP>3 </SUP>and a melt index MI2 of at least 0.3 g/10 mins, and up to 25 wt % of a pigmented polyethylene, wherein the total amount of pigment in the tape, fibre or filament is at least 0.5 wt %.
Patent PT-1824723-E (PT)
Title: Modular process to manufacture and assemble automotive vehicle structure, for passenger and load transportation, and resulting body and chassis
IPC: B62D21/02
Filed: 2005-12-05
Abstract: The present invention relates to the development of a modular process to manufacture and assemble an automotive vehicle structure, for passenger and load transportation, and resulting vehicle. The new conception for bodies construction, comprising a modular structure on an automotive vehicle chassis, with an assembly process allowing automatic manufacturing of bodies, by means of a panel-joining procedure, using the fewest number of components possible. The novel manufacturing and assembly process for automotive vehicle structure is able to allow a dynamic manufacturing process, not requiring welding, with the whole structure being modular. The resulting body has a modular structure comprising a front module (1), sides (2) and (21), ceiling (4), rear module (3), chassis (5), lower skirt (22), floor (27) and windows (28), joint by means of screws, rivets or a gluing process, as well as by metallic profiles (26), provided with rim (9), side rim (32), rail (23) and lower rim (36), by curve profile (19), which is provided with fitting areas (12), structural components (20) and curve structural elements (21) and structural components (35) and (34). The present descriptive report relates to a peculiar and original productive process for manufacturing and modular assembly of automotive vehicle structure, for passenger and load transportation, establishing a new conception for constructing bodies, using the least number of components possible.
Patent PT-1704864-E (PT)
Title: Injectable pharmaceutical preparation consisting of a cytostatic agent and a maleinimide linked by a spacer.
Inventor: KRATZ FELIX
IPC: A61K31/704
Filed: 2000-06-07
Abstract: Production of an injectable pharmaceutical composition comprises dissolving a drug derivative (I) in an injectable carrier liquid, where (I) comprises a drug linked to a protein-binding group via a spacer and where the spacer or the linkage between the drug and the spacer is pH-dependently or enzymatically cleavable in vivo to release the drug. An independent claim is also included for a drug derivative of type (I) in which the drug is not a cytostatic agent.
Patent PT-1838715-E (PT)
Title: Method for the preparation of maytansinoid esters
Inventor: CHARI RAVI V J
IPC: C07D491/12
Filed: 2006-01-20
Abstract: Improved processes for the preparation and purification of maytansinoid esters, especially thiol and disulfide-containing maytansinoids are described. In one aspect the process comprises a process of making a maytansinoid ester comprising forming an anion of maytansinol or a maytansinoid bearing a free C-3 hydroxyl moiety and reacting the anion with an activated carboxyl compound to thereby produce the maytansinoid ester.
Patent PT-1818645-E (PT)
Title: Improved sight with mobile red dot
Inventor: JOANNES RENE
IPC: F41G1/30
Filed: 2007-01-15
Abstract: The device has a fixed light source (4) producing a collimated light beam projected onto a reflecting blade (17) e.g. semi-transparent beamsplitter plate, so as to obtain a red dot or reticle. The light source has a collimator with a convergent lens and a quasi punctual luminous source placed in a focal point (8) of the lens of the collimator. An adjusting device is arranged to enable adjustment of an inclination angle of a rotating mirror (9) in relation to the light beam, where the adjusting device is provided with several scales for different ammunition.
Patent PT-2125736-E (PT)
Title: Substituted acetophenones useful as pde4 inhibitors
Inventor: FELDING JAKOB
IPC: A61P25/00
Filed: 2007-12-21
Abstract: The present invention relates to a compound according to formula: (1); wherein X1, X2, X3, X4 and X5 independently of each other represent -CH- or N; or X3, X4 and X5 independently of each other represent -CH- or N, and X1 and X2 independently of each other represent C and form part of an additional 6-membered aromatic ring; R1 represents hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, hydroxyalkyl, or alkylcarbonyl, all of which are optionally substituted; R2 and R3 independently represent hydrogen, -CH2, -C(O)NR-R', alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, haloalkyl, hydroxyalkyl, heterocycloalkenyl, alkylaryl, alkylalkoxycarbonyl, aikylcarbonyloxy, or alkoxyalkyl, all of which are optionally substituted; R11 represents hydrogen, halogen, cyano, amino, alkoxy or alkylamino, X1-X5 represent -CH- or N, including N-oxides, enantiomers and diastereomers; and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention relates further to methods of treating dermal disease.
Patent PT-2297136-E (PT)
Title: Insecticidal pyridylpiperidine compounds
Inventor: CORSI CAMILLA
IPC: C07D401/04
Filed: 2009-05-13
Abstract: A compound of formula (I): wherein R1 is pyrid-4-yl optionally substituted by one to four substituents independently selected from halogen, C1-3 alkyl or C1-3 haloalkyl; R2 is hydrogen, halogen, C1-4 haloalkyl or C1-4 haloalkoxy; R3 is trifluoromethyl, difluoromethyl or difluoromethoxy and R4 is hydrogen, fluoro or chloro, or R3 is fluoro, chloro or bromo and R4 is fluoro, chloro or trifluoromethyl; and R5 is hydrogen or halogen; or salts or N-oxides thereof. Furthermore, the present invention relates to intermediates used to prepare compounds of formula (I), to methods of using them to combat and control insect, acarine, mollusc and nematode pests and to insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising them.
Patent PT-661291-E (PT)
Inventor: PFLEIDERER WOLFGANG
IPC: C07H19/10
Filed: 1994-11-02
Abstract: A process for the preparation of oligoribonucleotides of the formula   <IMAGE> in which n, L, BB, W, T, Y', U, C<1> and C<2> are as defined in the description, by solid-phase synthesis, and intermediates of the formulae <IMAGE>  and <IMAGE> are described.u
Patent PT-652968-E (PT)
Inventor: IMLER JEAN-LUC
IPC: C12N15/12
Filed: 1994-05-27
Abstract: New replication-defective adenoviruses are selected from: (a) those that are derived from a natural adenovirus and lack at least the coding sequences of the E1B region and/or at least part of the E4 region; (b) those that are derived from a natural adenovirus other than a human type 5 adenovirus (Ad5) and lack part of the encapsidation region; (c) those that are derived from Ad5 and lack the part of the encapsidation region corresp. to nucleotides 270-346 in the Genbank M73260 sequence; and (d) those that are derived from Ad5 and lack the part of the encapsidation region corresp. to nucleotides 184-273 in the Genbank M73260 sequence. Also claimed is a eukaryotic cell contg. an adenovirus as above. Also claimed are: (1) a complementation line comprising a cell line contg. a complementation element which comprises at least part of the E1 region of a natural adenovirus and lacks the 5' ITR sequence, the element being integrated into the genome or inserted into a vector: and (2) a process for producing a defective adenovirus as above, comprising introducing the virus into a complementation line as above, culturing the cell line, and recovering the virus from the culture supernatant.
Patent PT-743869-E (PT)
Inventor: JOENSSON SVEN
IPC: F42B6/00
Filed: 1994-07-13
Abstract: PCT No. PCT/SE94/00691 Sec. 371 Date Sep. 20, 1996 Sec. 102(e) Date Sep. 20, 1996 PCT Filed Jul. 13, 1994 PCT Pub. No. WO95/21660 PCT Pub. Date Aug. 17, 1995A game of dart comprising safe darts and a board, wherein the darts are provided with blunt nose with a high-energy magnet, e.g. a neodymium magnet, surrounded by a sleeve of non-magnetic material, whereby the front end of the magnet forms the nose tip, and in that the board comprises a magnetic material and has a board picture built up by fields.
Patent PT-760655-E (PT)
Inventor: KOTWAL PRAMOD M
IPC: A61K9/50
Filed: 1995-03-16
Abstract: This invention is directed to a multilayered controlled release pharmaceutical dosage form. More particularly the dosage form is adapted for water soluble drugs and comprises a plurality of coated particles wherein each has multiple layers about a core containing a drug active whereby the drug containing core and at least one other layer of drug active is overcoated with a controlled release barrier layer and preferably an outer layer of additional drug is adapted for immediate release to preferably provide one immediate releasing layer and at least two controlled releasing layers of a water soluble drug from the multilayered coated particle.
Patent PT-824016-E (PT)
Inventor: CUBBER JAN PROSPER DENNIS DE
IPC: A61F13/12
Filed: 1996-08-14
Abstract: There is a device for regulating the force with which the cover body is pressed against the scar tissue, between the support body (3) and the cover body (2). This device can be operated by a pressure medium and, together with the cover body, forms an inflatable component. In an alternative form of the device, the scar tissue can be fed with a therapeutical medium in a controlled manner via the cover body. In this way, the scar can be treated from the exterior despite the presence of the cover body. The cover body is produced from a tissue-compatible polymer material.
Patent PT-814813-E (PT)
Inventor: ESSER KLAUS MAX
IPC: A61K38/21
Filed: 1996-03-05
Abstract: The present invention is directed to the use of a compound of Formula (A),or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing in the manufacture of a medicament for use in the treatment, including prophylaxis of HHV-8 infection.
Patent PT-883401-E (PT)
Inventor: GASPARO MARC DE
IPC: A61K31/4178
Filed: 1997-02-18
Abstract: The invention provides the use of an AT1 receptor antagonist, or a pharmaceutical salt thereof, for producing a pharmaceutical preparation for the stimulation of apoptosis and for the treatment of pathological symptoms which are substantially reduced, halted or prevented by apoptosis, and also corresponding pharmaceutical preparations.
Patent PT-910237-E (PT)
Inventor: CIVALLERI DAVIDE
IPC: A01D34/416
Filed: 1997-06-27
Abstract: A cutting head for a cutting machine, in particular a strimmer, having a hub (4) connected to a drive member (9) of the cutting machine, and a number of filiform elements (7) connected to and extending substantially radially from the hub (4); each pair of filiform elements (7) being defined by respective end portions (7a, 7b) of a single wire having a C-shaped intermediate portion (7c) housed firmly inside the hub.
Patent PT-918776-E (PT)
Inventor: MCMORRIS TREVOR C
IPC: C07C49/733
Filed: 1997-08-05
Abstract: The present invention provides compounds of formula I and methods for their synthesis: <CHEM> (wherein R' and R1 are independently (C1-C4) alkyl, R2 is OH and R3 is methyl).
Patent PT-977576-E (PT)
Inventor: CAVAZZA CLAUDIO
IPC: A61K31/565
Filed: 1998-04-03
Abstract: A pharmaceutical composition consisting essentially of an alkanoul L-camitine wherein the alkanoyl group is linear or branched and as 2-8 carbon atoms, dehydroepiandrosterone or.dehydroepiandrosterone sulphate.
Patent PT-1003486-E (PT)
Inventor: CHIESI PAOLO
IPC: A61P25/00
Filed: 1998-07-23
Abstract: A pharmaceutical composition in the form of effervescent tablets comprising an active ingredient and an effervescent blend, wherein the effervescent blend comprises an acidic component and sodium glycine carbonate as alkaline components. Preferred acid components are fumaric acid, maleic acid, and their salts. Tablets are prepared in normal thermo-hygrometric conditions and with standard tabletting equipment.
Patent PT-1007039-E (PT)
Inventor: NEOGI PARTHA
IPC: A61P3/10
Filed: 1999-05-07
Abstract: Novel diphenylethylene compounds containing thiazolidinedione or oxazolidinedione moieties are provided which are effective in lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes. In contrast to previously reported thiazolidine compounds, known to lower leptin levels, the present compound increase leptin levels and have no known liver toxicity.
Patent PT-1107996-E (PT)
Inventor: EATON DAN L
IPC: C07K16/40
Filed: 1999-08-26
Abstract: The invention provides for the isolation, identification, synthesis, expression and purification of antibodies reactive with factor IX (FIX)/factor IXa (IXa). In particular aspects, the invention provides human antibodies reactive with the human FIX Gla domain. The invention further provides compositions especially pharmaceutical compositions, articles of manufacture, and methods of inhibiting the activation of FIX and inhibiting FIX/IXa dependent coagulation.
Patent SG-1185-G (SG)
Title: 4-hydroxy-1, 2-benzisothiazol-3(2h)-one-1, 1-dioxide, their preparation and their utilization
IPC: C07D275/06
Filed: 1985-01-04
Abstract: Compounds of the formula   <IMAGE>   wherein R1 is hydrogen or hydroxyl, and non-toxic, pharmacologically acceptable salts thereof formed with inorganic or organic bases. The compounds as well as their salts are useful as sweetening agents.
Patent SG-43483-G (SG)
Title: Improvements in or relating to regenerative rotodynamic machines
IPC: F04D5/00
Filed: 1983-07-23
Abstract: in a regenerative rotodynamic machine, a portion of a disc-like impeller (11) adjacentthe impeller periphery extends radially through an annular chamber (<sub>1</sub>3) in the machine casing concentric with the impeller (17), thereby dividing said chamber into two annular side channels (13A, 13B) one on each side of the impeller. The portion of the impeller lying in the annular chamber has scooped out annular cavities or recesses in its sides in which are disposed rings of aerodynamic blades (18) and fluid flow passing around the annular chamber from an inlet to an outlet is caused to circulate repeatedly, flowing radially outward through the blading in the impeller cavities and radially inward in the annular side channels alongside the impeller outside the impeller cavities. The aerodynamic blades (18) are designed so that the angle between the entry and exit flows of each blade is greater than 90°.
Patent IE-33958-L (IE)
Title: Hairdressing composition
IPC: A61K/
Filed: 1970-01-27
Abstract: 1,243,470. Hairdressing. UNILEVER Ltd. 28 Jan., 1970 [31 Jan., 1969], No. 5431/69. Heading A5B. A hairdressing composition comprises an alcoholic or aqueous alcoholic solvent in which there is completely dissolved at least 0.1% by weight of the composition of a film-forming resin and at least 2% by weight of the composition of a water-insoluble lustre aid which is incompatible with the resin, where "incompatible" means that the lustre aid is immiscible with the resin so that it does not plasticise or soften the resin or otherwise substantially modify the hair-fixative properties of films of the resin.
[GB1243470A]
Patent IE-880252-L (IE)
Title: Rotary crusher for crushing rocks.
IPC: B02C19/00
Filed: 1988-01-29
Abstract: The rotor of the crusher receives the stones at its centre. It comprises three blades (20, 21) which, except on the ejecting edges (22), are protected against internal wear by their hollow shape which retains a protective layer of stones. These edges are protected from impacts by protecting plates (24) arranged radially in front of them.   <IMAGE>
Patent IE-780271-L (IE)
Title: Pesticidal formulation
IPC: A01N25/04
Filed: 1978-02-08
Abstract: The composition contains 10 to 75% of a herbicidal derivative of 2,6-dinitroaniline, such as trifluralin, 0 to 60% of a water-immiscible solvent (the herbicide and the solvent forming a homogenous disperse phase), 0.5 to 10% of an emulsifying agent and 15 to 70% of an aqueous solution of an inorganic salt such as NaCl, the salt representing at least 5% of the aqueous solution which may also contain urea (percentages expressed by weight). The compositions thus possess satisfactory storage stability characteristics while containing high herbicide concentrations. They can be used in agriculture, in pre-emergence treatment.
[GB1594991A]
Patent IE-890323-L (IE)
Title: Ophthalmic suspensions
IPC: A61K9/06
Filed: 1989-02-01
Abstract: Lightly crosslinked polymers, preferably ones prepared by suspension or emulsion polymerizing at least about 90 % by weight of a carboxyl-containing monoethylenically unsaturated monomer such as acrylic acid with from about 0.1 % to about 5 % by weight of a polyfunctional, and preferably difunctional, crosslinking agent such as divinyl glycol (3,4-dihydroxy-1,5-hexadiene), having a particle size of not more than about 50  mu m in equivalent spherical diameter, when formulated with an ophthalmic medicament, e.g., fluorometholone, into suspensions in aqueous medium in which the amount of polymer ranges from about 0.1 % to about 6.5 % by weight, based on the total weight of the aqueous suspension, the pH is from about 3.0 to about 6.5, and the osmotic pressure (osmolality or tonicity) is from about 10 mOsM to about 400 mOsM, provide new topical ophthalmic medicament delivery systems having suitably low viscosities which permit them to be easily administered to the eye in drop form, and hence be comfortably administrable in consistent, accurate dosages. These suspensions will rapidly gel in the eye after coming into contact with the eye's tear fluid to a substantially greater viscosity than that of the originally-introduced suspension and thus remain in place for prolonged periods of time to provide sustained release of the ophthalmic medicament.
Patent IE-870361-L (IE)
Title: Glycerophosphoryl-o-serine compositions
IPC: A61P25/28
Filed: 1987-02-12
Abstract: PCT No. PCT/EP87/00068 Sec. 371 Date Oct. 8, 1987 Sec. 102(e) Date Oct. 8, 1987 PCT Filed Feb. 12, 1987 PCT Pub. No. WO87/05024 PCT Pub. Date Aug. 27, 1987.Pharmaceutical compositions active on cerebral metabolism and on neuronal transmission containing as the active principle glycerophosphoryl-O-serine.
Patent IE-39057-L (IE)
Title: Orbital welding simulation.
IPC: B23K9/32
Filed: 1974-03-14
Abstract: This invention relates to a method and to devices for simulating the position welding of fixed metal members, specially of tubular members. To simulate the orbital welding of two fixed tubular members, two flat pieces of metal are disposed on a table supported by a rotary frame. This frame also supports a slideway, along which a carriage carrying one of several different welding heads is moved so that the torches of said welding heads be caused to travel along the close-spaced facing edges of the two flat pieces of metal. The carriage is moved in synchronism with the rotation of the rotary frame. This invention is applicable to the evaluation of automatic welding procedures for the construction of pipe lines for oil and miscellaneous fluids, such as gases and the like, as well as for the construction of other tubular metal structures.
[US3904845A]
Patent IE-830660-L (IE)
Title: Sleeve for cable joint
IPC: H02G15/076
Filed: 1983-03-25
Abstract: A sleeve (1) for protecting cable joints comprising a base cup (2) through which cables are led, a mating closure cap (4) and a resilient sealing ring (5) interposed therebetween. A clamping ring (9) is mounted on the cap (4) and is provided with three bayonet lugs (40) which interengage with complementary ramps (41) on rotation of the clamping ring (9) to draw the cup (2) and cap (4) together without relative rotation therebetween. A base insert (6) of heat resistant material is interference fitted into the cup (2). The insert (6) includes a flange (30) having a return (31) defining together with the rim (22) of the base cup (2) a channel (32) for entrapping a retaining part (35) of the sealing ring (5). Cables (3,80,81) to be joined are led through holes drilled in the base (76) of the cup (2) and insert (6). Those compartments (8) through which cables have been led are filled with a resin material to seal the cables in place and prevent ingress of moisture. The joints are then made and the lugs (40) on the clamping ring (9) are inserted through channel slots (15) in the cap (4) and aligned slots (20) in the cup (2). The ring (9) is then rotated relative the cup and cap so that abutting surfaces (43), (45) on the ramps (41) and lugs (40) interengage to draw the cup and cap together. A lip (55) extends radially inwardly of a return leg (43) of a lug (40) to engage under the lower edge of stop walls (16) to prevent removal of the clamping ring (9) from the cap (4).
Patent IE-840706-L (IE)
Title: Producing a protein-containing substance
IPC: C12N1/14
Filed: 1984-03-22
Abstract: The production of an edible protein-containing substance by continuous fermentation using Fusarium graminearum in a culture medium containing all necessary growth promoting nutrient substances. Oxygen constitutes the limiting nutrient and is present to support cell concentration in the culture without the occurrence of anaerobic growth.
[US4555485A]
Patent IE-890721-L (IE)
Title: 1,2,4-Benzotriazine Oxides as Radiosensitizers and Selective Cytotoxic Agents
IPC: A61K41/00
Filed: 1989-03-06
Abstract: A method of using 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents is disclosed. The compounds are shown to specifically radiosensitive hypoxic tumor cells and are additionnally disclosed to be useful as specific cytotoxic agents for these cells.
Patent IE-800901-L (IE)
Title: Sulphonamide solution
IPC: A61K31/635
Filed: 1980-05-02
Abstract: A clear solution of a sulphonamide and a potentiator comprises the sulphonamide and potentiator in a 5:1 weight ratio together with a polyamino acid and a non-reducing monosaccharide in a mixture of solvents, at least 50% of which is water, and the remainder consists of water-miscible organic solvents. The solvents are mixed, and monosaccharide and polyamino acid are first dissolved in the liquid mixture, after which the sulphonamide and potentiator are dissolved with stirring at room temperature or by slight heating.
[GB2048063A]